|
|
Vol. 7.09 – 15 March, 2021
|
|
|
|
|
|
|
|
Scientists developed a wound dressing material based on an integrated photo-crosslinking strategy and a microcapsule platform with pulsatile release of TGF-β inhibitor to achieve spatiotemporal specificity for skin wounds.
[Nature Communications]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
|
|
The authors demonstrated that blocking the MNK1/2-eIF4E axis inhibited melanoma phenotype switching and sensitized melanoma to anti-PD-1 immunotherapy. They showed that phospho-eIF4E-deficient murine melanomas expressed high levels of melanocytic antigens, with similar results verified in patient melanomas.
[Journal of Clinical Investigation]
|
|
|
|
|
|
Investigators demonstrated that ERK2 drove BRAF-mutant melanoma gene expression and proliferation as a function of its higher expression compared to ERK1.
[Molecular Cancer Research]
|
|
|
|
|
|
Researchers demonstrated that activation of NRF2 by FAM129B contributed to increased metastatic potential of BRAF V600E mutant melanoma cells. [Molecular Carcinogenesis]
|
|
|
|
|
|
Scientists showed that Twist1 had a direct role in maintaining the balance between proliferation and differentiation of keratinocytes and keratinocyte stem/progenitor populations.
[Molecular Carcinogenesis]
|
|
|
DERMAL STEM CELLS & TISSUE REGENERATION
|
|
|
|
|
|
Mice models of normal, diabetic, and diabetic+INK128 were constructed. Bone marrow-derived macrophages and RAW264.7 cell line co-cultured with myeloid-derived suppressor cells (MDSCs), which were induced at different conditions. Flow cytometry, western blot, quantitative real-time PCR, and immunohistochemical analysis were performed.
[Stem Cell Research & Therapy]
|
|
|
|
|
|
Researchers investigated the role of bone marrow-derived cells (BMDCs) in radiation-induced skin injury in bone marrow transplantation mice and observed that BMDCs contributed to skin recovery after ionizing radiation-induced barrier dysfunction.
[Scientific Reports]
|
|
|
|
|
|
|
|
The authors discuss the epigenetic changes that occur during wound healing and the rapidly expanding understanding of how these mechanisms affect healing resolution in both acute and chronic wound milieu. They also provide a focused overview of current research into epigenetic regulators that contribute to wound healing by specific cell type.
[Experimental Dermatology]
|
|
|
|
|
|
|
|
BiomX, Inc. announced that the first subject has been dosed in a Phase II cosmetic clinical study of BX001 in subjects with mild-to-moderate acne.
[BiomX, Inc.]
|
|
|
|
|
|
Eli Lilly and Company and Incyte, Inc. announced top-line results from BRAVE-AA2, a Phase III study evaluating the efficacy and safety of once-daily baricitinib 2-mg and 4-mg in adults with severe alopecia areata. [Incyte, Inc.]
|
|
|
|
|
|
|
|
June 21 – 26, 2021
Virtual
|
|
|
|
|
|
|
|
|
|
|
Mount Sinai Health System – New York, New York, United States
|
|
|
|
|
|
|
MD Anderson Cancer Center – Houston, Texas, United States
|
|
|
|
|
|
|
University of British Columbia – Vancouver, British Columbia, Canada
|
|
|
|
|
|
|
University of Washington – Seattle, Washington, United States
|
|
|
|
|
|
|
Portland VA Research Foundation – Portland, Oregon, United States
|
|
|
|
|
|